Bio Preventive Medicine (ROCO:6810) EPS (Basic): NT$-2.02 (TTM As of Dec. 2025)


ROCO:6810 Bio Preventive Medicine Corp ROCO:6810
50 GF Score
Price NT$25.10
GF Value NT$27.71
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Bio Preventive Medicine EPS (Basic)?

Bio Preventive Medicine ROCO:6810 -1.76% 50 EPS (Basic) is NT$-2.02 as of Dec. 2025. GuruFocus rates ROCO:6810 with a GF Score™ of 50/100 and a GF Value™ of NT$27.71 (Fairly Valued). The stock has 3 warning signs investors should review.

Bio Preventive Medicine's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NT$-1.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-2.02.

Bio Preventive Medicine's EPS (Diluted) for the six months ended in Dec. 2025 was NT$-1.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-2.02.

Bio Preventive Medicine's EPS without NRI for the six months ended in Dec. 2025 was NT$-1.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -2.02.

During the past 3 years, the average EPS without NRI Growth Rate was 0.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Bio Preventive Medicine's highest 3-Year average EPS without NRI Growth Rate was 6.60% per year. The lowest was -112.50% per year. And the median was -2.80% per year.

Bio Preventive Medicine  (ROCO:6810) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bio Preventive Medicine EPS (Basic) Related Terms

Bio Preventive Medicine EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Bio Preventive Medicine's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Preventive Medicine EPS (Basic) Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial -1.98 -2.03 -2.16 -2.47 -2.02

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.20 -1.22 -1.25 -0.99 -1.03
ROCO:6810
50GF Score
Bio Preventive Medicine Corp ROCO:6810
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Preventive Medicine EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bio Preventive Medicine's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-99.847-0)/49.449
=-2.02

Bio Preventive Medicine's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-50.759-0)/49.449
=-1.03

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$-2.02 mean?
Bio Preventive Medicine (ROCO:6810) has a EPS (Basic) of NT$-2.02 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bio Preventive Medicine and its competitors.
Is Bio Preventive Medicine's EPS (Basic) too high?
Bio Preventive Medicine's current EPS (Basic) is NT$-2.02. Overall, Bio Preventive Medicine has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio Preventive Medicine's EPS (Basic) compare to VRTX and REGN?
Bio Preventive Medicine's EPS (Basic) of NT$-2.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bio Preventive Medicine and its competitors. Bio Preventive Medicine's current EPS (Basic) is NT$-2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Preventive Medicine stock overvalued right now?
Based on GuruFocus' analysis, Bio Preventive Medicine (ROCO:6810) is currently considered Fairly Valued. The stock's GF Value™ is NT$27.71, compared to a current price of NT$25.10 — trading 9.4% below its estimated fair value. The current EPS (Basic) is NT$-2.02. Bio Preventive Medicine's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Bio Preventive Medicine (ROCO:6810), the current EPS (Basic) is NT$-2.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Preventive Medicine (ROCO:6810) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Preventive Medicine stock appears to be undervalued. The current stock price of NT$25.10 is trading 9.4% below its estimated GF Value™ of NT$27.71. GuruFocus considers Bio Preventive Medicine to be Fairly Valued.

Key valuation signals for ROCO:6810:

  • EPS (Basic): NT$-2.02
  • GF Value™: NT$27.71 vs. price of NT$25.10 (9.4% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6810 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio Preventive Medicine Business Description

Address No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is a clinical-stage biotech company, focusing on the early detection and prevention of diseases specialty of those high value-added molecular diagnostic products.
50GF Score

Get the complete analysis for ROCO:6810

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.10
Price
NT$27.71
GF Value